William Blair initiated coverage of Camp4 Therapeutics (CAMP) with an Outperform rating. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on CAMP: Camp4 Therapeutics initiated with an Overweight at JPMorgan Camp4 Therapeutics initiated with an Overweight at Piper Sandler Opening Day: Polyrizon, Gelteq debut in quiet IPO week